Government revenue is durable, counter-cyclical, and increasingly central to the defense-tech and dual-use thesis. It is also gated by qualifications, timelines, and cultural knowledge most portfolio companies don't have. Exprima gives your fund one advisory partner across all of it.
Founders pitch government TAM without understanding the gates between them and a contract: qualification timelines measured in months, capture cycles measured in years, and post-award obligations that can consume a commercial team. Funds are left pricing federal upside they cannot verify — and portfolio companies burn runway learning the market's rules one mistake at a time.
Exprima has spent 25 years winning and delivering federal programs. We know what a real federal path looks like, what it costs, and how long it takes — and we can tell you whether a company is on one.
One federal advisory partner across your portfolio. We work directly with each company on its own route — qualification, capture, and delivery — while giving the fund a portfolio-level view of federal progress, risk, and readiness against exit criteria.
Before you price a deal on government upside, we assess the target's real odds of winning and keeping federal work — a clear-eyed read from people who have carried programs through these gates for 25 years.
Multi-year contracts with option years, insulated from commercial demand cycles — the kind of revenue that holds a valuation together.
Authorizations, past performance, and vehicle access are expensive to earn and brutal to replicate — every gate cleared is a barrier competitors still face.
For dual-use and defense-tech theses, credible federal traction is no longer optional at exit — acquirers and underwriters check.
Start with a 30-minute call — about one deal on your desk, or the portfolio as a whole.
Schedule a call